Latest Cost Optimisation News

Westgold Resources reported a record A$80 million increase in cash, bullion, and liquid investments in Q3 FY25, maintaining steady gold production and cost guidance while advancing key mine ramp-ups and strategic divestments.

Northern Minerals has made significant progress on its Browns Range Heavy Rare Earths Project, advancing its feasibility study and exploration while raising $41.5 million, positioning itself as a strategic alternative amid growing geopolitical supply risks.

Bio-Gene Technology Limited has been awarded two significant grants totaling A$3 million by the US Department of Defense, validating its innovative insecticide technologies Flavocide® and Qcide®. The company is advancing regulatory filings and scaling production to target both military and civilian markets.

Challenger Limited reported a robust 12% increase in normalized NPAT to $225 million for 1H25, underpinned by strong earnings, dividend growth, and strategic investments in technology and distribution channels.

The a2 Milk Company posted robust first-half FY25 results, lifting revenue by 10.1% and net profit by 7.6%, while introducing a dividend policy for the first time. Strong English label IMF sales and liquid milk growth underpin an upgraded full-year outlook.

Computershare Limited reported a 6.7% decline in revenue to $1.5 billion for the half-year ended December 2024, primarily due to the sale of its US Mortgage Services business. However, profit after tax from continuing operations surged 24.9% to $286.5 million, underpinning an interim dividend of AU 45 cents per share.

Janison Education Group reported a steady 3% revenue increase in 1H FY25, underpinned by a 280% expansion in its customer pipeline and the operational launch of its AI platform. The company’s disciplined cost management and strategic leadership appointments position it for sustained growth in the global edtech market.

Spacetalk Ltd has secured a $428,853 R&D tax rebate from the Australian Taxation Office, reinforcing its commitment to innovation while reporting a 16% increase in Annual Recurring Revenue and significant cost reductions.

Yowie Group’s Q2 FY25 results reveal a mixed performance with a 33% revenue drop in North America offset by growth in Australia and ongoing cost optimisation efforts.

Argent BioPharma reports strategic cost-cutting moves including facility closures and delisting from the LSE, while securing German distribution approval and raising significant capital to support its drug pipeline.

Harvest Technology Group reported a robust 32% revenue increase and secured strategic partnerships to drive its path to profitability by FY27. The company also raised over $3 million through convertible notes to support expansion efforts.

Excite Technology Services has achieved positive EBITDA in December 2024, driven by strong revenue growth and record customer receipts, notably from its Digital Forensics division and the integration of CDFS.